Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited

Autor: Brian S. Cain, Daniel R. Meldrum, Joseph C. Cleveland, Alden H. Harken, Anirban Banerjee

Publikováno v: Circulation. 96(1)

Background Patients receiving oral hypoglycemic agents for diabetes mellitus are at increased risk of cardiovascular mortality. Oral hypoglycemic agents are inhibitors of the ATP-sensitive potassium (K ATP ) channel. Ischemic preconditioning is media

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c94c0be37278ea88eea10430c696658
https://pubmed.ncbi.nlm.nih.gov/9577959

Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents

Autor: B D, Prendergast

Publikováno v: Clinical pharmacy. 3(5)

The chemistry, pharmacology, pharmacokinetics, clinical efficacy, adverse effects, and dosage of glyburide and glipizide, two second-generation oral sulfonylurea hypoglycemic agents, are reviewed. Glyburide and glipizide are well absorbed after oral

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8809a8669df520937adb98a673aa52f6
https://pubmed.ncbi.nlm.nih.gov/6435940

Аналіз пероральних цукрознижувальних препаратів у нормативних документах, які регламентують лікування цукрового діабету 2-го типу

Autor: L. V. Yakovleva, A. L. Bilyk

Publikováno v: Управління, економіка та забезпечення якості в фармації; № 3(47) (2016); 75-80
Upravlìnnâ, ekonomìka ta zabezpečennâ âkostì v farmacìï; № 3(47) (2016); 75-80
Управление, экономика и обеспечение качества в фармации; № 3(47) (2016); 75-80

На теперішній час актуальність проблеми цукрового діабету (ЦД) і його ускладнень виходить на один рівень з онкологічними та серцево-суд�

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3aeadab86affd06d07b6ef8e5ea11fcc
https://doi.org/10.24959/uekj.16.33

Natural Products–Pyrazine Hybrids: A Review of Developments in Medicinal Chemistry.

Autor: Chen, Guo-Qing¹ (AUTHOR) 2022010882@ybu.edu.cn, Guo, Hong-Yan¹ (AUTHOR) hongyanguo@ybu.edu.cn, Quan, Zhe-Shan¹ (AUTHOR) zsquan@ybu.edu.cn, Shen, Qing-Kun¹ (AUTHOR) qkshen@ybu.edu.cn, Li, Xiaoting¹ (AUTHOR) luantian@symc.edu.cn, Luan, Tian² (AUTHOR) luantian@symc.edu.cn

Publikováno v: Molecules. Nov2023, Vol. 28 Issue 21, p7440. 59p.

Associations of somatic depressive symptoms with body mass index, systemic inflammation, and insulin resistance in primary care patients with depression.

Autor: Shell, Aubrey L.¹, Williams, Michelle K.¹, Patel, Jay S.², Vrany, Elizabeth A.³, Considine, Robert V.⁴, Acton, Anthony J.⁴, Stewart, Jesse C.¹ jstew@iupui.edu

Publikováno v: Journal of Behavioral Medicine. Dec2022, Vol. 45 Issue 6, p882-893. 12p. 1 Diagram, 2 Charts.